FGC
MD icon

Financial Gravity Companies’s Pediatrix Medical MD Stock Holding History

Financial Gravity Companies’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$27K Buy
+575
New +$31.5K 0.03% 481

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Financial Gravity Companies's MD Position: Q1 2018 in Review

Financial Gravity Companies opened a new position in Pediatrix Medical (MD) in Q1 2018: 575 shares worth $27K. The stake represents 0.03% of the portfolio and ranks #481 among its holdings.

342 funds tracked by Wall St. Rank hold MD as of Q1 2018.

  • Financial Gravity Companies held 575 shares of Pediatrix Medical worth $27K as of Q1 2018.
  • Pediatrix Medical was a new Financial Gravity Companies position in Q1 2018.
  • Pediatrix Medical made up 0.03% of Financial Gravity Companies's portfolio in Q1 2018, its #481 holding.
  • 342 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2018.

Based on Financial Gravity Companies's 13F filing for Q1 2018, filed 4 May 2018.